CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,516,000 | +0.4% | 101,386 | -27.4% | 0.56% | -7.4% |
| Q4 2018 | $2,507,000 | +6.1% | 139,569 | +73.5% | 0.61% | +38.3% |
| Q3 2018 | $2,363,000 | -4.1% | 80,441 | +48.4% | 0.44% | -8.0% |
| Q2 2018 | $2,464,000 | +6.6% | 54,197 | +23.8% | 0.48% | +10.9% |
| Q1 2018 | $2,311,000 | -15.0% | 43,761 | +9.4% | 0.43% | -23.8% |
| Q4 2017 | $2,719,000 | -9.7% | 39,989 | +9.5% | 0.56% | -32.7% |
| Q3 2017 | $3,010,000 | -36.8% | 36,529 | -28.2% | 0.84% | -40.5% |
| Q2 2017 | $4,765,000 | +79.8% | 50,895 | +22.3% | 1.41% | +112.7% |
| Q1 2017 | $2,650,000 | – | 41,625 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |